image credit: Adobe Stock

Andelyn Biosciences Opens New CGT Manufacturing Headquarters

On June 22, 2023, Andelyn Biosciences, a cell and gene therapy (CGT) contract development and manufacturing organization, announced the opening of its newly constructed manufacturing headquarters in Columbus, Ohio. According to a company press release, the 180,000-ft2 facility is intended to complement Andelyn’s two existing facilities in Columbus.

The new facility houses laboratory and manufacturing space, is regulatory-compliant, and more than triples Andelyn’s footprint to meet the growing demand for CGT services.

Read More on Biopharm International